Common Hormonal Contraceptive Linked to Risk of Rare Brain Tumor
Concerns are mounting over a potential link between a common hormonal contraceptive jab and the risk of rare brain tumors.
📍 How it ended
Reports linked a common hormonal contraceptive, including the Depo-Provera jab, to the risk of rare brain tumors. Victims called for risk warnings and updated drug guidance from NHS Scotland.
The story quieted without a definitive conclusion in the coverage.
Epilogue added 43d ago, after coverage quieted.
The obvious questions
Which contraceptive is linked to the brain tumors?
Coverage specifically identifies the Depo-Provera contraceptive jag.
What are the demands from victims in the UK?
Victims are calling for risk warnings to be provided to women and for NHS Scotland to update its drug guidance.
Which regulatory body has addressed this recently?
The European Medicines Agency (EMA) through its Pharmacovigilance Risk Assessment Committee (PRAC).
The story so far
Reports have emerged linking a hormonal contraceptive injection, specifically Depo-Provera, to the development of rare brain tumors. Individuals affected by inoperable tumors have spoken out, claiming they were not provided with adequate risk warnings before receiving the treatment.
Coverage from ScienceAlert, The Independent, and the New York Post emphasizes the health risks associated with the drug. In the UK, reports from Yahoo News UK and the Daily Record highlight calls for NHS Scotland to update its drug guidance to prevent further patients from being impacted.
Attention is currently on the European Medicines Agency (EMA), as recent meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) held July 6-9, 2026, address these safety concerns.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 43d ago.
Coverage (6)
- It’s not just Depo-Provera New York Post · 46d ago
- Depo contraceptive jag is a health disgrace and NHS Scotland must update drug guidance Yahoo News UK · 46d ago
- ‘I have an inoperable brain tumour after having the contraceptive jab’ The Independent · 46d ago
- "No woman should be given depo jag without risk warning" Victims left mutilated hit out Daily Record · 46d ago
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2026 European Medicines Agency (EMA) · 46d ago
- Common Hormonal Contraceptive Linked to Risk of Rare Brain Tumor ScienceAlert · 46d ago broke it first
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
Related trends
Pancreatic cancer breakthrough has big implications for early detection effort - San Diego Union-Tribune
Experimental cancer treatment Daraxonrasib is gaining momentum as regulators fast-track review and clinical data suggests potential advancements in patient care.
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026
Eli Lilly shares surge following a CHMP recommendation for Jaypirca's EU approval to treat chronic lymphocytic leukemia.